These nutritious seeds come with a variety of health benefits—but there are some potential side effects to be mindful of.

GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

Unregulated peptide injections have become popular in wellness circles, used for everything from building muscle mass to ...

Medically reviewed by Lindsay Cook, PharmD Black seed oil (Nigella sativa), also called black cumin or black caraway, is a ...

Medically reviewed by Patricia Mikula, PharmD Ashwagandha is generally safe and well-tolerated, but may have side effects ...

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing authorizations for Teva’s biosimilars PONLIMSI and DEGEVMA ...

We’ve all heard how social media is devastating teen mental health — but a shocking new report confirms it’s robbing pretty much everyone of the ability to focus. The meta-study from Griffith ...

Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced the US Food and Drug ...

The Food and Drug Administration (FDA) has approved Osvyrti ® (denosumab-desu), a biosimilar to Prolia ® (denosumab), and Jubereq ® (denosumab-desu), a biosimilar to Xgeva ® (denosumab). Osvyrti is ...

Products will treat osteoporosis and skeletal-related events from certain types of bone cancer, expanding the company's biosimilar portfolio Approved for all of the same indications of its reference ...

Osvyrti and Jubereq are FDA-approved denosumab biosimilars for osteoporosis and cancer-related skeletal events, interchangeable with Prolia and Xgeva, respectively. Clinical trials confirmed ...